 improv insulin-induc glucos dispos obes patient niddm treatment d-fenfluramin object short-term effect serotoninerg anorect drug d-fenfluramin insulin-induc glucos dispos research design and method random double-blind placebo-control crossov trial treatment period mg/day d-fenfluramin obes subject normal oral glucos toler non-insulin-depend diabet niddm weight-maintain diet euglycemic-hyperinsulinem glucos clamp measur glucos kinet D- patient niddm patient niddm insulin deliveri rate result nondiabet subject signific chang metabol hormon paramet basal state clamp slight reduct bodi weight kg diabet patient signific chang bodi weight basal plasma insulin level blood glucos level mM plasma free fatti acid concentr microm d-fenfluramin placebo clamp insulin metabol clearanc rate mcr similar placebo d-fenfluramin endogen hepat glucos product suppress wherea glucos dispos d-fenfluramin averag increas glucos mcr conclus mechan treatment d-fenfluramin induc blood control insulin sensit obes patient niddm independ signific weight reduct last effect present obes subject normal oral glucos toler